{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:10:01Z","timestamp":1778879401560,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"National High level Hospital Clinical Research Funding"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177855","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T02:29:38Z","timestamp":1750386578000},"page":"177855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Peroxiredoxin 2 alleviates myocardial ischemia-reperfusion injury by inhibiting platelet activity via the AKT\/NF-\u03baB pathway"],"prefix":"10.1016","volume":"1002","author":[{"given":"Chengying","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9993-1458","authenticated-orcid":false,"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.ejphar.2025.177855_bib1","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/eurheartj\/ehv104","article-title":"Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention","volume":"36","author":"Aradi","year":"2015","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177855_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177855_bib3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1042\/BST20170013","article-title":"Transcriptional regulators of redox balance and other homeostatic processes with the potential to alter neurodegenerative disease trajectory","volume":"45","author":"Burnside","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177855_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2022.10.023","article-title":"Timing, selection, modulation, and duration of P2Y(12) inhibitors for patients with acute coronary syndromes undergoing PCI","volume":"16","author":"Capodanno","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"issue":"25","key":"10.1016\/j.ejphar.2025.177855_bib5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.123.064473","article-title":"Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the academic research consortium","volume":"147","author":"Capodanno","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ejphar.2025.177855_bib6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3390\/biomedicines12081689","article-title":"Eugenol: a potential modulator of human platelet activation and mouse mesenteric vascular thrombosis via an innovative cPLA2-NF-\u03baB signaling axis","volume":"12","author":"Chang","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177855_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030585","article-title":"The perspectives of platelet proteomics in health and disease","volume":"12","author":"Chaudhary","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177855_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/db22-0553","article-title":"Isorhapontigenin attenuates cardiac microvascular injury in diabetes via the inhibition of mitochondria-associated ferroptosis through Prdx2-MFN2-ACSL4 pathways","volume":"72","author":"Chen","year":"2023","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177855_bib9","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/CIR.0000000000000985","article-title":"Mechanical complications of acute myocardial infarction: a scientific statement from the American heart association","volume":"144","author":"Damluji","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177855_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110714","article-title":"The role of PI3K\/AKT signaling pathway in myocardial ischemia-reperfusion injury","volume":"123","author":"Deng","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177855_bib11","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1007\/s12035-023-03787-w","article-title":"Targeting NF-\u03baB in hepatic ischemia-reperfusion alleviation: from signaling networks to therapeutic targeting","volume":"61","author":"Deng","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177855_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12192-013-0442-y","article-title":"Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease","volume":"19","author":"El Eter","year":"2014","journal-title":"Cell Stress Chaperones"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177855_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.blre.2016.03.002","article-title":"NF-\u03baB signaling pathway as target for antiplatelet activity","volume":"30","author":"Fuentes","year":"2016","journal-title":"Blood Rev."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177855_bib14","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2010.3723","article-title":"Toll-like receptors: new players in myocardial ischemia\/reperfusion injury","volume":"15","author":"Ha","year":"2011","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177855_bib15","first-page":"10","article-title":"Myocardial ischemia\/reperfusion: Translational pathophysiology of ischemic heart disease","volume":"5","author":"Heusch","year":"2024","journal-title":"Med N. Y. N"},{"key":"10.1016\/j.ejphar.2025.177855_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121791","article-title":"Garcinol acts as a novel integrin \u03b1IIb\u03b23 inhibitor in human platelets","volume":"326","author":"Hsia","year":"2023","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177855_bib17","doi-asserted-by":"crossref","first-page":"G387","DOI":"10.1152\/ajpgi.00350.2018","article-title":"AKT activator SC79 protects hepatocytes from TNF-\u03b1-Mediated apoptosis and alleviates d-Gal\/LPS-Induced liver injury","volume":"316","author":"Jing","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177855_bib18","article-title":"Peroxiredoxins-the underrated actors during virus-induced oxidative stress","volume":"10","author":"Karpenko","year":"2021","journal-title":"Antioxid. Basel Switz."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177855_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jtha.2023.07.025","article-title":"Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond","volume":"22","author":"Kumar","year":"2024","journal-title":"J. Thromb. Haemost. JTH."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177855_bib20","first-page":"301","article-title":"Searching for NF-kappaB-Based treatments of ischemia reperfusion injury","volume":"22","author":"Latanich","year":"2009","journal-title":"J. Investig. Surg. Off. J. Acad. Surg. Res."},{"key":"10.1016\/j.ejphar.2025.177855_bib21","article-title":"Peroxiredoxin2 (Prdx2) reduces oxidative stress and apoptosis of myocardial cells induced by acute myocardial infarction by inhibiting the TLR4\/Nuclear factor kappa B (NF-\u03baB) signaling pathway","volume":"26","author":"Li","year":"2020","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ejphar.2025.177855_bib22","article-title":"Prdx2 protects against atherosclerosis by regulating the phenotype and function of the vascular smooth muscle cell","volume":"8","author":"Li","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177855_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.111.245530","article-title":"Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-Deficient mice","volume":"109","author":"Park","year":"2011","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177855_bib24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bbagen.2013.08.001","article-title":"Peroxiredoxins as biomarkers of oxidative stress","volume":"1840","author":"Poynton","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.ejphar.2025.177855_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101398","article-title":"Novel therapeutic strategies to reduce reperfusion injury after acute myocardial infarction","volume":"47","author":"Sch\u00e4fer","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177855_bib26","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3389\/fimmu.2019.01260","article-title":"Platelet contributions to myocardial ischemia\/reperfusion injury","volume":"10","author":"Schanze","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177855_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/a-1739-9351","article-title":"Platelets in myocardial ischemia\/reperfusion injury","volume":"43","author":"Schanze","year":"2023","journal-title":"H\u00e4mostaseologie"},{"key":"10.1016\/j.ejphar.2025.177855_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fncel.2017.00099","article-title":"Phospholipase A2 of Peroxiredoxin 6 plays a critical role in cerebral ischemia\/reperfusion inflammatory injury","volume":"11","author":"Shanshan","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177855_bib30","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.3390\/ijms23095232","article-title":"Prdx2 knockdown inhibits extracellular matrix synthesis of chondrocytes by inhibiting Wnt5a\/YAP1\/CTGF and activating IL-6\/JAK2\/STAT3 pathways in deer antler","volume":"23","author":"Sun","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177855_bib31","article-title":"Peroxiredoxins in neurodegenerative diseases","volume":"9","author":"Szeliga","year":"2020","journal-title":"Antioxid. Basel Switz."},{"issue":"15","key":"10.1016\/j.ejphar.2025.177855_bib32","doi-asserted-by":"crossref","first-page":"13304","DOI":"10.1074\/jbc.M110.192138","article-title":"The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4","volume":"286","author":"Takac","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177855_bib33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCULATIONAHA.113.008157","article-title":"Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia\/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging","volume":"130","author":"von Elverfeldt","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177855_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2023.06.022","article-title":"What do we know about platelets in myocardial ischemia-reperfusion injury and why is it important?","volume":"229","author":"Wang","year":"2023","journal-title":"Thromb. Res."},{"issue":"17","key":"10.1016\/j.ejphar.2025.177855_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176408","article-title":"The phenomenon of clopidogrel high On-Treatment platelet reactivity in ischemic stroke subjects: a comprehensive review","volume":"21","author":"Wi\u015bniewski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177855_bib37","doi-asserted-by":"crossref","first-page":"H692","DOI":"10.1152\/ajpheart.00634.2005","article-title":"Activated platelets contribute importantly to myocardial reperfusion injury","volume":"290","author":"Xu","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"16","key":"10.1016\/j.ejphar.2025.177855_bib38","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jacc.2023.07.031","article-title":"Comparison of antiplatelet monotherapies after percutaneous coronary intervention according to clinical, ischemic, and bleeding risks","volume":"82","author":"Yang","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177855_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119529","article-title":"Sp1-Mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis","volume":"278","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.177855_bib40","article-title":"The pathological mechanisms and potential therapeutic drugs for myocardial ischemia-reperfusion injury","volume":"129","author":"Zhang","year":"2024","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177855_bib41","first-page":"111","article-title":"A single-chain Antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia\/reperfusion injury","volume":"39","author":"Ziegler","year":"2018","journal-title":"Eur. Heart J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:20:18Z","timestamp":1778876418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925006090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"alternative-id":["S0014299925006090"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177855","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxiredoxin 2 alleviates myocardial ischemia-reperfusion injury by inhibiting platelet activity via the AKT\/NF-\u03baB pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177855"}}